Darmstadt, 12 November 2026
Merck has presented its quarterly figures in Darmstadt, exceeded expectations and subsequently raised its targets again.
The pharmaceutical group Merck has closed its quarter with figures that were above market expectations. In the same announcement, the group again raised its targets. This confirms Merck's positive development in the current financial year on the one hand and its confidence in the coming months on the other.
The news item refers to the group's announcement from Darmstadt. In the accompanying report, Merck is regularly discussed in relation to quarterly figures, revenue development, EBITDA and important business segments such as Mavenclad. The comparison with expectations forms the starting point of the news item before the company explains its raised targets.
